CDC Anthrax Researcher Resigns

The former head of a US Centers for Disease Control and Prevention biosecurity lab has left his post amidst safety retooling at government labs.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDCMichael Farrell, the former head of the US Centers for Disease Control and Prevention (CDC) Bioterror Rapid Response and Advanced Technology Laboratory, who last month was reassigned in the wake of the biosecurity oversight that exposed agency scientists to anthrax, has now resigned. CDC spokesperson Thomas Skinner told The New York Times that Farrell’s resignation was voluntary. “It was his decision,” Skinner said.

Farrell led the Bioterror Rapid Response and Advanced Technology Laboratory, which handles potentially dangerous materials including pathogens like Bacillus anthracis, since 2009. As The Guardian pointed out, Farrell is the first government employee to leave his post following a string of lab safety mishaps that have led to increased scrutiny.

In media interviews, Sean Kaufman, a former CDC employee who’s now president of the consulting firm Behavioral-Based Improvement Solutions, defended Farrell. “He’s a scapegoat and everybody knows that,” Kaufman, who was asked to testify at last week’s House hearing on biosecurity issues in government labs, told USA Today. “For [Farrell] to resign as a result of this is an indicator that they’re focusing on who instead of what. It was a culture that led to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide